Whitestone REIT Board of Trustees Declares Third Quarter 2015 Dividend

20:00 EDT 7 Jun 2015 | Globe Newswire

HOUSTON, June 8, 2015 (GLOBE NEWSWIRE) -- Whitestone REIT (NYSE:WSR) ("Whitestone") announced today that its Board of Trustees has declared a quarterly cash dividend for the 2015 third quarter of 28.5 cents per share on the Company's common stock and Operating Partnership units. The third quarter dividend will be paid in three installments of 9.5 cents each in July, August and September. The record and payment dates for the third quarter period are as follows:

Month Record Date Payment Date
July 7/2/2015 7/9/2015
August 8/3/2015 8/10/2015
September 9/2/2015 9/9/2015

"We are pleased to be declaring a cash dividend of 28.5 cents per share for the 21st quarter in a row," said James C. Mastandrea, Chairman and Chief Executive Officer. "This clearly demonstrates the strength of our cash flow and the successful execution of our forward–thinking business model of adding value through buying, operating and redeveloping service-based Community Centered PropertiesTM."

About Whitestone REIT

Whitestone REIT (NYSE:WSR) is a fully integrated real estate investment trust ("REIT") that owns, re-develops, repositions, leases, manages and operates Community Centered PropertiesTM.  Whitestone focuses on value creation in its community centers, concentrating on local service-oriented tenants. Whitestone's diversified tenant base provides service offerings including specialty retail, grocery, restaurants, medical, educational and financial services.  Founded in 1998, the Company is internally managed with a portfolio of 65 commercial properties in Texas, Arizona, and Illinois.  For additional information about the Company, please visit

CONTACT: Whitestone REIT
         Bob Aronson, Director of Investor Relations
         (713) 435-2219

Whitestone REIT


More From BioPortfolio on "Whitestone REIT Board of Trustees Declares Third Quarter 2015 Dividend"

Quick Search


Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...